{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:04:38Z","timestamp":1777878278999,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"national center for advancing translational sciences","doi-asserted-by":"publisher","award":["UL1TR002733"],"award-info":[{"award-number":["UL1TR002733"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Hematology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The optimal treatment of patients with systemic diffuse large B-cell (DLBCL) or high-grade B-cell (HGBL) lymphomas with synchronous central nervous system (CNS) involvement at diagnosis is not well defined. High-dose methotrexate administered concurrently with R-CHOP (RM-CHOP) is a commonly used regimen, but data on outcomes achieved with this regimen are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To report our experience with RM-CHOP in patients with systemic DLBCL or HGBL with synchronous CNS involvement at diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A single-center retrospective analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified consecutive patients with systemic DLBCL or HGBL with synchronous CNS involvement at diagnosis who were treated with RM-CHOP from January 2012 to January 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifty patients were included with a median age of 62\u2009years; 82% had DLBCL ( n\u2009=\u200941) and 18% had HGBL ( n\u2009=\u20099). Treatment with RM-CHOP was followed by consolidative autologous hematopoietic cell transplantation in 14 patients (28%). The complete response (CR) rate following RM-CHOP was 62%. With a median follow-up of 40\u2009months, the median progression-free (PFS) and overall (OS) survivals were 16 and 58\u2009months, and the 2-year PFS and OS were 41% and 57%, respectively. The 2-year cumulative incidence of CNS progression\/relapse was 29%. Outcomes were particularly poor in HGBL, with median PFS and OS of 6 and 7\u2009months, compared with median PFS and OS of 22\u2009months and not reached in DLBCL, respectively. The outcomes of patients with relapsed\/progressive disease were poor, with only 63% of patients receiving subsequent treatments and only 21% achieving CR to next subsequent treatment. Most patients (58%) with disease relapse\/progression had CNS involvement which was associated with very poor outcomes (median OS of 2\u2009months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CNS involvement in aggressive B-cell non-Hodgkin lymphoma at diagnosis dictates clinical outcomes and requires more effective treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20406207221112900","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T08:06:15Z","timestamp":1658563575000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study"],"prefix":"10.1177","volume":"13","author":[{"given":"Megan","family":"Fleming","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Dotson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Bond","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Reneau","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lapo","family":"Alinari","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Brammer","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Christian","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kami","family":"Maddocks","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-3671","authenticated-orcid":false,"given":"Yazeed","family":"Sawalha","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, 1140B Lincoln Tower, 1800 Cannon Dr, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"bibr1-20406207221112900","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"bibr2-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-737320"},{"key":"bibr3-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1002\/hon.881"},{"key":"bibr4-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1654097"},{"key":"bibr5-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12982"},{"key":"bibr6-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"bibr7-20406207221112900","unstructured":"Younes A, Sehn LH, Johnson P, et al. Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non-germinal center B-cell diffuse large B-cell lymphoma. J Clin Oncol 2019; 37: 1285\u20131295, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30901302"},{"key":"bibr8-20406207221112900","unstructured":"Bartlett NL, Wilson WH, Jung S-H, et al. Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance\/CALGB 50303. J Clin Oncol 2019; 37: 1790\u20131799, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30939090"},{"key":"bibr9-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-578963"},{"key":"bibr10-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.2157"},{"key":"bibr11-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000141301"},{"key":"bibr12-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145128"},{"key":"bibr13-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006926"},{"key":"bibr14-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.05.016"},{"key":"bibr15-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"bibr16-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"bibr17-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005999"},{"key":"bibr18-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12451"},{"key":"bibr19-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25558"},{"key":"bibr20-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1159\/000517531"},{"key":"bibr21-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13867"},{"key":"bibr22-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14267"},{"key":"bibr23-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.08.100"},{"key":"bibr24-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.02.009"},{"key":"bibr25-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16064"},{"key":"bibr26-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30366-5"},{"key":"bibr27-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.1236"},{"key":"bibr28-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1285026"},{"key":"bibr29-20406207221112900","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.126110"},{"key":"bibr30-20406207221112900","volume":"4","author":"Ferreri AJM","year":"2017","journal-title":"Lancet Haematol"},{"key":"bibr31-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00306"},{"key":"bibr32-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301077"},{"key":"bibr33-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.2980"},{"key":"bibr34-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70481-3"},{"key":"bibr35-20406207221112900","volume":"1","author":"Greb A","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr36-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30444-8"},{"key":"bibr37-20406207221112900","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.070839"},{"key":"bibr38-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129097"},{"key":"bibr39-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14187"},{"key":"bibr40-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118538"},{"key":"bibr41-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017014845"},{"key":"bibr42-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.2019363"},{"key":"bibr43-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"bibr44-20406207221112900","volume":"7","author":"Kalakonda N","year":"2020","journal-title":"Lancet Haematol"},{"key":"bibr45-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30225-4"},{"key":"bibr46-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00139-X"},{"key":"bibr47-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"bibr48-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001694"},{"key":"bibr49-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005292"},{"key":"bibr50-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"bibr51-20406207221112900","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2021-147913","volume":"138","author":"Kamdar M","year":"2021","journal-title":"Blood"},{"key":"bibr52-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1561"},{"key":"bibr53-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0649-7"},{"key":"bibr54-20406207221112900","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016077907952"}],"container-title":["Therapeutic Advances in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207221112900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406207221112900","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207221112900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:16:15Z","timestamp":1777590975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406207221112900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["10.1177\/20406207221112900"],"URL":"https:\/\/doi.org\/10.1177\/20406207221112900","relation":{},"ISSN":["2040-6207","2040-6215"],"issn-type":[{"value":"2040-6207","type":"print"},{"value":"2040-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20406207221112900"}}